Summary:
A randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of study medication in subjects with moderate to severe Endometriosis-associated pain.
Qualified Participants Must:
• Be female
•
Be between 18 and 49 years of age
•
Have endometriosis
Qualified Participants May Receive:
Study medication and compensation for time and travel.